180 related articles for article (PubMed ID: 21105150)
41. Human prostate cancer progression models and therapeutic intervention.
Chung LW; Kao C; Sikes RA; Zhau HE
Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
[TBL] [Abstract][Full Text] [Related]
42. Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation.
Heinrichs AA; Banerjee C; Bortell R; Owen TA; Stein JL; Stein GS; Lian JB
J Cell Biochem; 1993 Nov; 53(3):240-50. PubMed ID: 8263041
[TBL] [Abstract][Full Text] [Related]
43. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
[TBL] [Abstract][Full Text] [Related]
44. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
[TBL] [Abstract][Full Text] [Related]
45. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
46. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
47. Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.
Haviv YS; van Houdt WJ; Lu B; Curiel DT; Zhu ZB
Mol Cancer Ther; 2004 Jun; 3(6):687-91. PubMed ID: 15210854
[TBL] [Abstract][Full Text] [Related]
48. A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma.
Akita H; Ishiba R; Togashi R; Tange K; Nakai Y; Hatakeyama H; Harashima H
J Control Release; 2015 Feb; 200():97-105. PubMed ID: 25543000
[TBL] [Abstract][Full Text] [Related]
49. The potential of virus-based gene therapies for treatment of metastatic kidney cancer.
Dent P; Curiel DT; Fisher PB
Expert Rev Anticancer Ther; 2011 Jun; 11(6):809-11. PubMed ID: 21707273
[No Abstract] [Full Text] [Related]
50. [Gene therapy for the treatment of prostate cancer using osteocalcin promoter].
Gotoh A; Terao S; Shirakawa T; Fujisawa M; Kamidono S
Nihon Rinsho; 2011 Jun; 69 Suppl 5():550-3. PubMed ID: 22208042
[No Abstract] [Full Text] [Related]
51. Vitamin D status may explain racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
Grant WB
Cancer; 2016 Dec; 122(24):3892-3893. PubMed ID: 27627191
[No Abstract] [Full Text] [Related]
52. Reply to vitamin D status may explain racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
Rose TL; Milowsky MI
Cancer; 2016 Dec; 122(24):3893. PubMed ID: 27627047
[No Abstract] [Full Text] [Related]
53. Editorial Comment: Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies.
Gregorio BM
Int Braz J Urol; 2021; 47(4):745-746. PubMed ID: 33848066
[No Abstract] [Full Text] [Related]
54. The mechanism of action of induced membranes in bone repair.
Aho OM; Lehenkari P; Ristiniemi J; Lehtonen S; Risteli J; Leskelä HV
J Bone Joint Surg Am; 2013 Apr; 95(7):597-604. PubMed ID: 23553294
[TBL] [Abstract][Full Text] [Related]
55. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.
Bittner T; Zetterberg H; Teunissen CE; Ostlund RE; Militello M; Andreasson U; Hubeek I; Gibson D; Chu DC; Eichenlaub U; Heiss P; Kobold U; Leinenbach A; Madin K; Manuilova E; Rabe C; Blennow K
Alzheimers Dement; 2016 May; 12(5):517-26. PubMed ID: 26555316
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.
Ilie M; Long-Mira E; Funck-Brentano E; Lassalle S; Butori C; Lespinet-Fabre V; Bordone O; Gay A; Zahaf K; Poissonnet G; Lacour JP; Bahadoran P; Ballotti R; Gros A; Dutriaux C; Saiag P; Merlio JP; Vergier B; Emile JF; Hofman V; Hofman P
J Am Acad Dermatol; 2015 May; 72(5):786-93. PubMed ID: 25659223
[TBL] [Abstract][Full Text] [Related]
57. Genetic polymorphisms of serum amyloid A1 and coronary artery disease risk.
Xie X; Ma YT; Yang YN; Li XM; Zheng YY; Liu F; Ma X; Fu ZY; Yu ZX; Chen Y; Chen BD; Huang Y
Tissue Antigens; 2015 Mar; 85(3):168-76. PubMed ID: 25656165
[TBL] [Abstract][Full Text] [Related]
58. The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
Jansson S; Bendahl PO; Grabau DA; Falck AK; Fernö M; Aaltonen K; Rydén L
PLoS One; 2014; 9(7):e102176. PubMed ID: 25025175
[TBL] [Abstract][Full Text] [Related]
59. The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
Mimura K; Shiraishi K; Mueller A; Izawa S; Kua LF; So J; Yong WP; Fujii H; Seliger B; Kiessling R; Kono K
J Immunol; 2013 Dec; 191(12):6261-72. PubMed ID: 24244023
[TBL] [Abstract][Full Text] [Related]
60. Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.
Podgornik H; Sok M; Kern I; Marc J; Cerne D
Pathol Res Pract; 2013 Aug; 209(8):516-20. PubMed ID: 23880163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
